Track topics on Twitter Track topics that are important to you
Dyadic International Inc's (NASDAQ:DYAI) chief operating officer Matthew Jones speaks to Proactive London during what's been a significant week for the company as it begins trading on Nasdaq.
The Jupiter, Florida-based biotechnology platform company, engages in the development, and large scale manufacture of low-cost enzymes and other proteins for diverse market opportunities in the United States and Europe.
Original Article: Milestone for Dyadic International as it begins trading on NasdaqNEXT ARTICLE
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...